-
PBS (Phosphate-Buffered Saline): Technical Parameters and La
2026-07-08
PBS (Phosphate-Buffered Saline) addresses the need for a sterile, isotonic buffer solution with physiological pH stability in laboratory research. It is designed for applications such as cell washing and reagent dilution where controlled osmolarity and non-toxicity are critical. This product is not suitable for diagnostic, clinical, or in vivo use.
-
Gallein (SKU B7271): Optimizing GPCR Signaling and Viability
2026-07-08
Gallein (SKU B7271) is a rigorously validated G protein βγ subunit inhibitor that empowers biomedical researchers to dissect GPCR signaling with reproducibility across cancer, immunology, and cardiometabolic models. This article offers scenario-driven guidance on assay optimization, data interpretation, and vendor selection, ensuring robust experimental outcomes and workflow efficiency.
-
LC–MS/MS Mapping of GS-441524 Prodrug Conversion Pathways
2026-07-07
This study introduces a novel GS-441524 prodrug (NGP-1) with structural modifications to improve oral bioavailability and anti-SARS-CoV-2 potential. Using a newly established LC–MS/MS method, the research reveals detailed in vitro and in vivo conversion pathways, informing both pharmacokinetic profiling and future antiviral drug development.
-
NSC 87877: Shp2 Inhibitor Workflows for Neuroinflammation St
2026-07-07
NSC 87877 from APExBIO empowers precise, selective inhibition of Shp2, enabling robust dissection of neuroinflammatory and oncogenic signaling pathways. Its high potency and specificity translate into reproducible workflows for both mechanistic studies and advanced disease modeling.
-
Phenylmethanesulfonyl Fluoride (PMSF): Assay Integrity in Fo
2026-07-06
This article explores how Phenylmethanesulfonyl fluoride (PMSF, SKU A2587) delivers robust, reproducible results in cell viability, proliferation, and cytotoxicity assays. Through scenario-driven Q&A, we address real-world experimental pitfalls and detail why APExBIO’s PMSF is a trusted, evidence-backed choice for serine protease inhibition.
-
Stable Isotope UHPLC-MS/MS for Methylated Purine Quantificat
2026-07-06
This study presents a robust stable isotope-diluted UHPLC-MS/MS method for the accurate quantification of ten methylated purine nucleosides, including 1-methyl Adenosine, in cultured cells. The protocol offers improved sensitivity, recovery, and isomer resolution, facilitating advanced RNA modification research and biomarker discovery in disease contexts.
-
LY294002: Applied PI3K/Akt/mTOR Pathway Inhibition Workflows
2026-07-05
LY294002 empowers precise modulation of PI3K/Akt/mTOR and related pathways, enabling researchers to dissect apoptosis, autophagy, and fibrosis mechanisms in both cancer and fibrotic disease models. This guide translates recent mechanistic findings into actionable protocols, troubleshooting strategies, and advanced applications for reliable, reproducible results.
-
Okadaic acid: Practical Guide for PP1/PP2A Inhibition Studie
2026-07-04
Okadaic acid enables precise inhibition of protein phosphatase 1 (PP1) and protein phosphatase 2A (PP2A) in biochemical and cell-based workflows, facilitating the investigation of phosphorylation-dependent signaling, apoptosis induction, and related processes. It is best applied in controlled research settings where off-target phosphatase inhibition and solvent effects are monitored. Use outside validated assays or in workflows sensitive to broad phosphatase disruption is not recommended.
-
BMAL1 Phase Separation Regulates Circadian Transcriptional H
2026-07-03
Gao et al. reveal that BMAL1, a core circadian clock factor, forms dynamic nuclear condensates through phase separation, directly linking its intrinsically disordered region and phosphorylation state to the timing and robustness of circadian transcription. These findings clarify a longstanding gap in how transcriptional feedback loops are temporally coordinated, with significant implications for studying protein phosphorylation in clock regulation.
-
Y-27632 and ROCK Inhibition: Decoding Cytoskeletal Repair Pa
2026-07-03
Explore how the selective ROCK inhibitor Y-27632 advances cytoskeletal dynamics research and cellular regeneration. This deep dive reveals novel applications and mechanistic insights for ROCK signaling pathway studies.
-
HSP90 Modulates DMPK RNA Foci in Myotonic Dystrophy Type 1
2026-07-02
This study uncovers HSP90 as a novel regulator of DMPK mRNA expression and RNA foci formation in Myotonic Dystrophy type 1 (DM1) muscle cells. By linking HSP90 and p-STAT3 signaling to disease-relevant RNA homeostasis, the work highlights new molecular targets for therapeutic intervention and provides a foundation for future studies on RNA foci modulation.
-
Lactate-Induced HMGB1 Modifications Drive Sepsis Severity
2026-07-02
This study reveals that lactate actively promotes HMGB1 lactylation and acetylation in macrophages during polymicrobial sepsis, leading to increased exosomal HMGB1 release and endothelial permeability. The findings suggest new intervention strategies targeting lactate-mediated signaling in sepsis pathogenesis.
-
Quantifying Methylated Purine Nucleosides via Stable Isotope
2026-07-01
This study introduces a highly sensitive stable isotope-diluted UHPLC-MS/MS method for accurately quantifying ten methylated purine nucleosides, including 1-methyl Adenosine, in cellular models. The approach significantly advances RNA modification research by resolving isomers, improving detection limits, and enabling robust biomarker discovery relevant to cancer metabolism and other diseases.
-
Latrunculin B: Precise Actin Cytoskeleton Disruption Tool
2026-07-01
Latrunculin B is a potent and reversible actin polymerization inhibitor widely used for transient disruption of actin filaments in cellular studies. Its mechanism—direct G-actin binding—enables precise, short-term manipulation of cytoskeletal organization. Latrunculin B's selectivity, rapid onset, and defined limitations underpin its status as a gold standard for actin dynamics research.
-
SERCA Inhibition by BHQ Enhances HSC Mobilization via ER Str
2026-06-30
Li et al. (2025) reveal that selective SERCA inhibition with 2,5-di-tert-butylbenzene-1,4-diol (BHQ) induces mild endoplasmic reticulum stress, enhancing hematopoietic stem cell (HSC) mobilization through modulation of the CaMKII-STAT3-CXCR4 pathway. These findings offer a mechanistically novel strategy to improve HSC collection for transplantation and advance the study of calcium signaling in stem cell biology.